Geniculate Nerve Block Versus Adductor Canal Block for ACL Reconstruction Surgery
1 other identifier
interventional
40
1 country
1
Brief Summary
Anterior cruciate ligament repair (ACL) surgery presents moderate to severe pain during the inmediate postoperative period and the first days after surgery. In addition, due to the interest of surgeons and patients for early reinstatement, the use of blockages that decrease the strength of the quadriceps is avoided. Therefore, in recent years, the adductor canal block (ACB) has been used for postoperative analgesia with variable results. Genicular nerve block (GNB) has been used for pain management in patients with knee osteoarthritis and recently in knee arthroplasty surgery with results similar to the local anesthetic infiltration techniques by the surgeon (LIA). Considering their good results in these patients in addition to being a 100% sensitive block without risk of motor involvement. The investigators proposed this experimental study to evaluate tha analgesic efficacy of the genicular nerve block (GNB) compared with the adductor canal block (ACB) for the Anterior cruciate ligament (ACL) repair surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2024
CompletedStudy Start
First participant enrolled
June 26, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedJuly 3, 2024
June 1, 2024
3 months
May 2, 2024
June 26, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Pain assessed by NRS at PACU
Numerical raiting score (NRS) 0-10 (0= No pain; 10=maximum pain)
up to 6 hours postoperative
Opioid consumption at PACU
Metadone consumption in mg.
up to 6 hours postoperative
Secondary Outcomes (2)
Pain score at home
up to 24 hours
Quality of rest
First night
Study Arms (2)
Adductor canal block
EXPERIMENTALInjection of local anaesthetics under ultrasound guidance in the adductor canal by the anaesthesiologist prior the surgery, after inducction of general anesthesia.
Genicular nerve block
EXPERIMENTALInjection of local anaesthetics under ultrasound guidance in the genicular nerves ( Superomedial genicular nerve, superolateral genicular nerve and inferomedial genicular nerve) by the anaesthesiologist prior the surgery, after inducction of general anesthesia.
Interventions
Injection of the local anesthetic prior to the surgery, either in the the adductor canal or in the genicular nerves by the anesthesiologist under ultrasound guidance.
Eligibility Criteria
You may qualify if:
- Patients from 18 to 50 years old scheduled to undergo anterior cruciate ligament reconstruction
You may not qualify if:
- peripheral neuropathy
- pre-existing femoral neuropathy
- diabetes mellitus
- alcoholism
- drug addiction
- cancer with chemotherapy
- chronic pain state
- Negative of the patient to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Clinic
Barcelona, 0836, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 2, 2024
First Posted
July 3, 2024
Study Start
June 26, 2024
Primary Completion
September 30, 2024
Study Completion
December 30, 2024
Last Updated
July 3, 2024
Record last verified: 2024-06